Related Experiment Video
Updated: Oct 13, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Curricular-driven screening for atrial fibrillation at community pharmacies
Community pharmacies can effectively screen for atrial fibrillation (AF) using student pharmacists. This feasible model, utilizing KardiaMobile devices, identifies potential AF cases and offers a sustainable approach to preventative cardiovascular care.
Area of Science:
- Cardiology
- Public Health
- Pharmacy Practice
Background:
- Atrial fibrillation (AF) significantly elevates stroke risk.
- Undiagnosed AF often presents asymptomatically, necessitating community-based screening.
- A sustainable model is required to detect unrecognized AF in the community.
Purpose of the Study:
- To evaluate a curriculum-driven model for AF screening in community pharmacies.
- Assess the feasibility and sustainability of using student pharmacists for AF detection.
- Examine the value and logistics of implementing AF screening in independent pharmacies.
Main Methods:
- Fourth-year pharmacy students conducted AF screenings during advanced pharmacy practice rotations.
- KardiaMobile, an FDA-cleared ECG device, was used for patient assessments.
- Semi-structured interviews with pharmacists evaluated program logistics, value, and sustainability.
Main Results:
- Over 7 months, 8 students screened 63 patients across 3 pharmacies, with most encounters under 10 minutes.
- 4.7% of screened patients (3 individuals) showed possible AF.
- Pharmacies reported high value (8.8/10) and professional (9.7/10) scores for the screening initiative.
Conclusions:
- Curriculum-integrated AF screening in community pharmacies is a feasible model.
- Student pharmacists offer a sustainable workforce for this clinical initiative.
- Further research on population-based AF detection is needed to confirm stroke risk reduction and potential reimbursement.
Related Concept Videos
Dysrhythmias V: Evaluating Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Dysrhythmias VI: Management of Dysrhythmias

